![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Stentys Nabs FDA Clearance for Longest Version of Xposition Stent
Stentys Nabs FDA Clearance for Longest Version of Xposition Stent
The FDA has granted clearance to Stentys’ 37 mm Xposition S sirolimus-eluting self-apposing stent.
The clearance bolsters the company’s existing Xposition stent portfolio, which already consists of three lengths –17-, 22- and 27 mm.
The stents are intended to adjust to vessels with fluctuating diameters to eliminate malapposition issues linked to traditional stents. — Anisa Jibrell
Upcoming Events
-
11Jul
-
18Jul
-
21Oct